Compare DRTS & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRTS | DBL |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | Israel | United States |
| Employees | 125 | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 546.5M | 293.6M |
| IPO Year | N/A | N/A |
| Metric | DRTS | DBL |
|---|---|---|
| Price | $7.25 | $14.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 269.7K | 74.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.67% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,055.39 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $14.46 |
| 52 Week High | $8.60 | $16.01 |
| Indicator | DRTS | DBL |
|---|---|---|
| Relative Strength Index (RSI) | 52.24 | 39.57 |
| Support Level | $6.51 | $14.46 |
| Resistance Level | $7.77 | $15.56 |
| Average True Range (ATR) | 0.52 | 0.09 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 41.74 | 41.37 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.